GRTS Crosses Above Average Analyst Target
January 20, 2021 at 08:39 AM EST
In recent trading, shares of Gritstone Oncology Inc (GRTS) have crossed above the average analyst 12-month target price of $13.67, changing hands for $22.27/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..